A B S T R A C T Seminal plasma diluted
INTRODUCTION
Highly effective biological mechanisms must be present to protect antigenically foreign spermatozoa from the cellular and humoral immune mechanisms potentially active in the female genital tract. These immunological mechanisms probably evolved to protect sensitive steps in reproduction, but also could function to promote the survival and enhance the virulence of Neisseria gonorrhoeae and other agents that cause sexually transmitted diseases.
Seminal plasma from humans, mice, and cattle contains a variety of poorly characterized, but potent, substances that inhibit in vitro reactions of lymphocytes from homologous or heterologous species (1) (2) (3) (4) . Seminal plasma inhibits pokeweed mitogen, phytohemagglutinin, concanavalin A, tetanus toxoid, and Candida antigen-induced lymphocyte activation. Seminal plasma also inhibits allogeneic cell stimulation in the mixed lymphocyte reaction as well as the generation of cytotoxic T cells against tumor antigens. Mouse antisheep erythrocytes in vitro plaque responses to T celldependent and -independent antigens are inhibited. This broadly active seminal plasma lymphocyte inhibitory activity elutes in a high-molecular weight peak from a Sephadex G-150 column.
The purpose of this report is to present observations on seminal plasma inhibition of antibody and complement-mediated bactericidal and opsonic systems.
METHODS
Human specimens used in this study were obtained under the guidelines of the University of California San Francisco, Committee on Human Research.
Seminal plasma, The seminal plasma specimens were from unidentified donors. The specimens had been collected for routine laboratory evaluations of infertility/fertility, for postvasectomy evaluations, and from normal volunteers. The specimens were allowed to liquify at room temperature, centrifuged to remove sperm, and frozen at -13°C. Specimens obtained in this manner were thawed, recentrifuged (5,000 g, 10 min) and pooled in volumes of 5-20 ml. Aliquots were frozen and stored at -70°C. Before use, the specimens were thawed, recentrifuged, and filtered through a 0.45-,m pore size filter (Millipore Corp., Bedford, Mass.). The centrifugation steps removed almost all sperm and no sperm were visible by light microscopy after the filtration step. A few specimens were handled individually in the same manner as the pooled specimens for evaluation of specimen-to-specimen variation of activity. Additionally, one large volume of pooled seminal plasma was kindly provided by Dr. Chung Lee and associates, Northwestern University School of Medicine.
Sera. Human sera used in these studies were obtained from blood drawn by venipuncture. The blood was clotted, centrifuged, and the sera were frozen in small aliquots at -700C within 90 min. Normal sera were obtained from healthy young adults. Complement-donor sera (Cd)' were from five patients with marked hypogammaglobulinemia; these sera were used individually as sources of complement. Gonorrhea patient sera were collected from study patients as described (5, 6) . Immune human sera to Neisseria meningitidis sero-groups A, B, C, and Y were kindly provided by Dr. J. McCloud Griffiss, Walter Reed Army Institute for Research. Rabbit sera immune to N. meningitidis were kindly supplied by Dr. Neylan Vedros, University of California, Berkeley. Serum deficient in the eighth component of complement (C8) was obtained from a patient previously described in detail (7) . Serum deficient in the seventh component of complement (C7) was kindly provided by Dr. Terrence J. Lee, University of North Carolina (8) .
Bacterial isolates. The N. gonorrhoeae isolates studied were from the authors' culture collection (5, 6 (5) (6) (7) . Heat-inactivated (56°C, 30 min) test serum was serially diluted from 1:10 to 21:5,120 for analysis of titer of bactericidal activity. The Neisseria species were grown 16-18 h on GCI agar and dispersed in medium 199 to make the inocula. The gram-negative rods were grown to log phase in Mueller-Hinton broth, sedimented by centrifugation and diluted in medium 199 to make the inocula.
The bactericidal assays for N. gonorrhoeae and N. meningitidis were done using a replicator device as described (6) with an inoculum of -6 x 103 colony forming units (cfu)/ ml in a total vol of 0.25 ml. Bactericidal assays for gram-negative rods were done using an inoculum of about 1 x 104 cfu/ml in snap-cap plastic tubes with a total vol of 1.0 ml; rapid and large amounts of growth of the gram-negative rods precluded counting of colonies when bactericidal assays on these organisms were done with the replicator.
Serum immunoglobulins were fractionated by the method of Griffiss (10) and the purified immunoglobulin preparations were used in bactericidal assays.
Opsonization, phagocytosis, and killing assays. The opsonization experiments were done with modifications of the techniques of Klebanoff (11, 12) . To prepare leukocytes from peripheral blood, 10-ml vol of whole blood from normal donors were mixed with 10-ml vol of 2% dextran T 250 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) in physiological saline, pH 7.4. After sedimentation of the erythrocytes for 20 min, the supernates were collected and the leukocytes were gently pelleted (150 g, 10 min). The leukocytes were washed with 0.87% ammonium chloride to lyse the remaining erythrocytes, recentrifuged, mixed with calciumfree Krebs-Ringer phosphate buffer, and the percent and absolute number of polymorphonuclear cells were enumerated in a hemocytometer.
The studies of opsonization of N. gonorrhoeae and E. coli 014-K7 used C8-or C7-deficient sera as complement sources because sera with intact complement systems were bactericidal. The C8-and C7-deficient sera had normal opsonic activities (7, 8) . Normal sera or C8 deficient serum were used to opsonize S. aureus.
To make inocula for the opsonization studies, the Neisseria species were grown and prepared in the same manner as for the bactericidal assays. The E. coli and S. aureus were grown to log phase in Mueller-Hinton broth, washed with water, and diluted in medium 199. In the opsonization assays, the inocula were 2-4 x 107 cfu/ml and the numbers of polymorphonuclear cells were Seminal plasma and attachment of immunoglobulins and the third component of complement (C3) to gonococci. To test the effect of seminal plasma on immunoglobulin binding, C8-deficient serum was serially diluted 1:2-1:1,024 and reacted with 107 cfu of N. gonorrhoeae strain g867 or E. coli 014-K7, in buffered medium for 30 min at 37°C. The organisms were washed once, resuspended in phosphate-buffered saline, and 25 Al was dropped on a glass slide, air dried, and gently heat fixed. The spot was overlayed witlh 25 Al of previously titered fluorescein-conjugated goat antibody to heavy chains of human IgG, IgM, or IgA (N. L. Cappel Laboratories, Inc., Cochranville, Pa.). After incubation for 30 min at 370C, the slides were washed, air dried, and scored for degree of fluorescence as follows: no staining or 1 + were considered negative fluorescence; 2+ to 4+ were considered positive. To test the influence of seminal plasma on immunoglobulin binding to organisms, 10% seminal plasma was preincubated with the organisms for 20 min before addition of the C8-deficient serum.
A similar set of experiments was done using radiolabeled anti-human goat antibodies. lodination of the IgG fraction of goat anti-human IgG, IgM, and IgA heavy chain specific antibodies (N. L. Cappel Laboratories, Inc.) was done using described techniques (13, 14) . Briefly, glass tubes were coated with 200 ,ml of 2% IODO-GEN (Pierce Chemical Co., Rockford, Il.) in methylene chloride. The tubes were dried with nitrogen gas. In a separate tube, the immunoglobulin (6 x 10-10 mol) was mixed with 20 ,ul of 17 Ci/mg'25I (New England Nuclear, Boston, Mass.) and 3.5 tl of 0.1% KI. The volume was adjusted to 100 ,l with 0.125 M Na borate-0.075 M NaCl, pH 8.2. The reaction was initiated by transferring the immunoglobulin solution to the IODO-GEN-coated tube and allowed to proceed at 4°C for 5 min with gentle agitation. The reaction was terminated by chromatographing the mixture on a Sephadex G-100 (Pharmacia Fine Chemicals, Inc. Piscataway, N. J.) column equilibrated with 1% bovine serum albumin in phosphate-buffered saline.
The 125I-labeled antibodies were used to test the attachment of the human immunoglobulins (from C8-deficient serum or normal serum) using a technique similar to that used for the fluorescein-labeled anti-immunoglobulin experiments. The sera were diluted from 1:10 to 1:10,000 and reacted with the bacteria. After incubation and washing to remove excess serum, unlabeled goat antiserum containing the 125I-labeled antibody as a tracer was added to each pellet and incubated at room temperature for 30 min. The pellets were washed four times and the 1251 activity in the bacterial pellets was determined.
The C8-deficient serum was used to test for C3 attachment to N. gonorrhoeae and E. coli. Fluorescein conjugated anti-C3 antibody (N. L. Cappel Laboratories, Inc.) was used to stain for C3. Fluorescence was graded the same as for the immunoglobulin attachment.
Chemiluminescence assays. Polymorphonuclear cell chemiluminescence was assayed by the method of Stevens et al. (15) . Briefly, human polymorphonuclear cells were prepared as for the phagocytosis experiments. For preopsonization, E. coli were incubated for 30 min at 370C in 50% fresh autologous normal serum, pelleted, and resuspended in the Krebs-Ringer phosphate buffer. Luminol (Sigma Chemical Co., St. Louis, Mo.) was kept in a stock 0.1-M solution in dimethyl sulfoxide and diluted for use in Krebs-Ringer phosphate buffer. The chemiluminescence was measured in a Searle liquid scintillation counter (Searle Radiographics Inc., Des Plaines, Ill.) with one photomultiplier tube disconnected; vials were counted for 30 s at 10-min intervals. The components of the chemiluminescence assays were mixed together in dark adapted liquid scintillation vials just before the initial determinations ofcounts per minute. The 2-ml chemiluminescence assays contained the following components, singly or in various combinations: 105 polymorphonuclear cells; 5 x 106 cfu ofE. coli; nM phorbal myristic acid (Sigma Chemical Co.); 0.1 ,uM Luminol; 1 or 10% seminal plasma; and Krebs-Ringer phosphate buffer.
Complement assays. Hemolytic whole complement (CHN) assays were performed in three separate laboratories using described techniques (16) (17) (18) . In each of the laboratories, sheep erythrocytes were obtained from the Colorado Serum Co., Denver, Colo., and preserved in modified Alsever's solution. Rabbit antisera (hemolysin) to sheep erythrocytes was purchased from Gibco Laboratories, Grand Island Biological Company, Grand Island, N. Y. or from BBL Microbiology Systems.
Studies of the seminal plasma characteristics. Crude seminal plasma was chromatographed on a 2.6 x70-cm Sephadex G-25 (Pharmacia Fine Chemicals, Inc.) column equilibrated with 0.5% NH4HCO3. After spectrophotometrically measuring absorption at 280 nm, protein fractions were pooled. Pools were lyophilized for 24-72 h to concentrate the samples; this procedure removed essentially all of the NH4HCO3 (NH3 and CO2) as monitored by change in pH to neutrality. Dialysis of crude seminal plasma and of pooled elution fractions was done in standard cellulose dialysis tubing for 24 h against 0.5% NH4HCO3. The dialyzed materials and the dialysates were concentrated by lyophilization; the concentrated materials were screened for inhibitory activity at dilutions of 1:2.5.
Seminal plasma diluted 1:2 was treated with trypsin (Sigma Chemical Co.) in a final concentration of 1.25-2.5 mg/ml of seminal plasma. The mixture was incubated for 4 h at room temperature or at 37°C. Trypsin activity was stopped with soybean trypsin inhibitor used at the same concentrations as trypsin. These preparations were tested for effects of seminal plasma bactericidal inhibitory activity. Similar experiments were done using the soybean trypsin inhibitor alone, chymotrypsin (Sigma Chemical Co.) at 1.25-2.5 mg/ml of seminal plasma, and protease type IV (Sigma Chemical Co.) at the same concentrations.
Purified spermine and spermidine used in bactericidal assays (Sigma Chemical Co.) were supplied by Dr. Laurence Marton, University of California, San Francisco. The spermine and spermidine were used in concentrations approximating those in seminal plasma.
Protein determinations on seminal plasma were done by the method of Lowry et al. (19) .
Statistical analysis of bactericidal data. A decrease of >40% of the cfu per milliliter in a bactericidal assay was significant compared with that in a sample obtained at zero time. The 40% decrease was more than the 95% confidence limits (P < 0.05) determined by comparing zero time and 40-min samples from more than 75 paired heated serum controls (5, 6) . Heated sera were not bactericidal. In experiments designed to measure the titers of active materials, there was very rarely a difference of more than one dilution in the bactericidal titers determined on different days. We found no differences of more than two dilutions. Each experiment was performed at least twice and at the most four to six times with comparable results each time.
Student's t test was used to test significance of differences in phagocytic indices.
RESULTS
Seminal plasma inhibition of serum killing of N. gonorrhoeae. Seminal plasma diluted 1:5 markedly inhibited the bactericidal action of serum on N. gonorrhoeae. As demonstrated in Fig. 1 , with the addition of (Table I) . After dilution of S591-3 to 1:1,000, the seminal plasma inhibitory titers were 1:640 to .1:5,120. Heated (56°C, 30 min) S591-3 was diluted 1:100 or 1:1,000, a standard amount of complement was added, and the inhibitory titers of seminal plasma (6) specimens were determined.
Seminal plasma inhibition of serum killing of other bacteria. The specificity of seminal plasma inhibition of serum bactericidal action was tested with other species of bacteria. Bactericidal action of heat-inactivated serogroup specific rabbit immune serum plus human complement, or heat-inactivated human immune serum plus complement, for N. meningitidis also was markedly inhibited by seminal plasma (Fig. 2) plasma were not bactericidal. Seminal plasma also inhibited the bactericidal action of 10% fresh normal human serum with intact complement for the highly serum susceptible strain E. coli 014-K7 (Fig. 3) . Seminal plasma inhibition of the serum bactericidal effect on other gram-negative rods was less pronounced (Table II) and appeared to be related to the susceptibility of the organisms to 10% normal human serum. Seminal plasma inhibition of opsonization, phagocytosis and killing ofgonococci and E. coli. N. gonorrhoeae and E. coli opsonized by C8-deficient serum were phagocytosed and killed by polymorphonuclear cells. Seminal plasma inhibited one or more components of the sequence as measured by the endpoint of bacterial viability (Figs. 4 and 5) . Nearly identical results were found when C7-deficient serum was used as the opsonin and N. gonorrhoeae was the test organism. In five experiments, seminal plasma had no apparent effect on normal serum or C8-deficient serum opsonization and polymorphonuclear cell phagocytosis and killing of S. auerus 502A.
Phagocytic indices. Seminal plasma appeared to inhibit the association of N. gonorrhoeae or E. coli with (24) and may enhance the killing in Chediak-Higashi syndrome (25) . Seminal plasma is a biochemically complex material and it is likely that its effects on polymorphonuclear cells are not simple.
Seminal plasma did not inhibit the attachment of immunoglobulins to gonococci and E. coli, but did inhibit bactericidal action when hypogammaglobulinemic complement donor serum was used with immune serum or purified IgM or IgG.
Seminal plasma significantly reduced serum whole hemolytic complement activity. Hemolytic assays are far more sensitive than bactericidal or opsonization assays as measures ofcomplement function. Addition of 100 U of C8 to C8-deficient serum repletes CH50 activity, but 10,000 U are required to replete bactericidal activity (7) . It is likely the seminal plasmainduced reduction in CH50 activity is sufficient to explain the inhibition of bactericidal and opsonic activities. This possibility is strongly supported by the observations that hemolytic titers of C3 in N. gonorrhoeae and E. coli bactericidal reactions are markedly reduced in the presence of seminal plasma, and no bactericidal action occurs (21) . Seminal plasma also inhibits alternate pathway activity, cleaves factor B, depresses the functional capacity of C1 and C3 by more than 50% and reduces the functional activities of some erythrocyte antibody complement-stable intermediates. Singly or collectively, these seminal plasma effects on complement function could inhibit antibody complement-mediated bactericidal and opsonic activities. The detection of bound C3 by the fluorescein-labeled anti-C3 antibody is interesting, but does not negate the probable anticomplementary effect of seminal plasma. The C3 detected on the surface of the bacteria could have been an opsonically inactive C3 fragment such as C3d. This would not have been differentiated by the fluorescein-labeled antibody.
The chromatography and dialysis characteristics of the seminal plasma inhibitory factor indicate that it is a small molecule, probably <20,000 mol wt. However, the chemical nature of the bactericidal inhibitor remains unknown. It is not a polyamine, based on the experiments using purified polyamines and does not appear to have sulfur containing residues affected by dithiothreitol. It also is unlikely the inhibitory effect is due to chelation. The calcium and magnesium concentrations in the buffered medium 199 should have been far in excess of the amount that could be removed by seminal plasma chelation effects.
The susceptibility of the seminal plasma inhibitory factor to heating at 100°C is compatible with the inhibitory substance being a protein. Seminal plasma contains a large number of proteins including enzymes and enzyme inhibitors-many of which are low molecular weight (22, (26) (27) (28) (29) . That we were not able to modify the seminal plasma bactericidal inhibitory activity using a limited number of proteases and a protease inhibitor does not exclude the possibility that the bactericidal inhibitor is a low-molecular weight protein with enzyme or enzyme inhibitory action. Also, it is possible that there is more than one seminal plasma inhibitory substance.
The seminal plasma bactericidal inhibitor appears to be different from the inhibitor of lymphocyte activation. The latter has a molecular weight of > 100,000 (3), whereas the bactericidal inhibitor activity can be found in both the low-and high-molecular weight fractions from Sephadex G-25 columns. The presence of the bactericidal inhibitor in both fractions suggests that it may be bound to a higher molecular weight substance or that it may be the cleavage product of a higher molecular weight substance.
C3 has been detected in cervical mucus (30, 31) and it has been suggested that C3 is synthesized in vitro by vaginal mucosa (32) . CH50 activity equivalent to 11.5% of serum levels has been found in human mid-cycle cervical mucus (33) . Both serum and secreted immunoglobulins are present in the female genital tract (27, 30, 31, 34) . The combination of complement and immunoglobulins in the cervix could function in a protective manner (35, 36) and may result in the generation of chemotaxins and in opsonization of N. gonorrhoeae. These potentially protective actions of complement and antibodies in the female genital tract would be effectively blocked by seminal plasma.
